Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT02896452
What this trial is testing

Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovarian SyndromeIdiopathic Intracranial Hypertension
National Aeronautics and Space Administration 60
Early research (Phase 1)Study completedNCT04364464
What this trial is testing

Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Who this might be right for
Clinical Pharmacology
Bayer 40
Large-scale testing (Phase 3)Ended earlyNCT00042887
What this trial is testing

Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 58
Early research (Phase 1)Study completedNCT06720714
What this trial is testing

Assess the Concentration of Rozanolixizumab in the Breast Milk of Healthy Lactating Women

Who this might be right for
Healthy Participants
UCB Biopharma SRL 15
Early research (Phase 1)Study completedNCT05918588
What this trial is testing

Determine the Effect of Multiple Oral Doses and Regimens of KD025 in Healthy Male and Post-menopausal Female Subjects

Who this might be right for
Immune System Disorder (Healthy Volunteer)
Kadmon, a Sanofi Company 32
Testing effectiveness (Phase 2)Study completedNCT02649829
What this trial is testing

Autologous Dendritic Cell Vaccination in Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University Hospital, Antwerp 28
Large-scale testing (Phase 3)Looking for participantsNCT07472153
What this trial is testing

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Who this might be right for
Metastatic Cervical CancerPersistent Cervical CancerRecurrent Cervical Cancer
N.N. Alexandrov National Cancer Centre 120
Early research (Phase 1)Study completedNCT03178695
What this trial is testing

Inovium Ovarian Rejuvenation Trials

Who this might be right for
Perimenopausal DisorderMenopauseMenopause, Premature+17 more
Ascendance Biomedical 200
Early research (Phase 1)Active Not RecruitingNCT05783622
What this trial is testing

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+4 more
Janux Therapeutics 130
Large-scale testing (Phase 3)Study completedNCT01797445
What this trial is testing

Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIVHIV Infections
Gilead Sciences 872
Testing effectiveness (Phase 2)Study completedNCT05074472
What this trial is testing

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

Who this might be right for
Solid Tumor, AdultPancreatic Ductal; AdenocarcinomaOvarian Serous Adenocarcinoma+2 more
ZielBio, Inc. 35
Post-approval studies (Phase 4)Study completedNCT04599075
What this trial is testing

Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus

Who this might be right for
Type 1 DiabetesPregnancy, High Risk
Gianna Wilkie 70
Early research (Phase 1)Study completedNCT01137708
What this trial is testing

CP-690,550 And Oral Contraception Drug-Drug Interaction Study

Who this might be right for
Healthy
Pfizer 20
Early research (Phase 1)Study completedNCT01655056
What this trial is testing

Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the Body

Who this might be right for
PharmacokineticsPharmacodynamicsHealthy Subjects+2 more
Astellas Pharma Europe B.V. 82
Early research (Phase 1)Study completedNCT02897375
What this trial is testing

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

Who this might be right for
Solid NeoplasmStage III Pancreatic CancerStage IIIA Breast Cancer+14 more
Emory University 71
Early research (Phase 1)Not Yet RecruitingNCT07793929
What this trial is testing

Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Who this might be right for
End Stage Renal DiseaseRenal ImpairmentObesity+1 more
Kailera 32
Early research (Phase 1)Ended earlyNCT04429321
What this trial is testing

Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary

Who this might be right for
Renal Cell CarcinomaRenal Cell Carcinoma Stage IV
Abramson Cancer Center at Penn Medicine 1
Large-scale testing (Phase 3)Study completedNCT00045292
What this trial is testing

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01855711
What this trial is testing

Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)

Who this might be right for
Irritable Colon
GlaxoSmithKline 32
Early research (Phase 1)Study completedNCT02817464
What this trial is testing

Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle

Who this might be right for
PregnancyContraception
Teva Branded Pharmaceutical Products R&D, Inc. 12
Next Page